Guidelines Emphasize Personalized, Interprofessional Diabetes Care
The American Diabetes Association provides clinical recommendations for managing diabetes with a focus on personalized, interprofessional care. This approach considers individual preferences, cultural factors, and barriers to care.
Guidelines Highlight Key Approaches for Managing Diabetic Retinopathy, Neuropathy, and Foot Care
Recent guidelines by the American Diabetes Association (ADA) recommend addressing diabetic retinopathy with proper glycemic control, blood pressure, and lipid management. Intensive management can delay or prevent retinopathy progression, and screening is advised for all individuals with type 1 or type 2 diabetes.
Revised Approaches for Diabetes Overtreatment in Older Patients With Type 2 Diabetes
Recent clinical guidelines recommend avoiding “diabetes overtreatment” in older individuals with type 2 diabetes (T2D), which refers to excessively low glycemia that increases the risk of side effects like hypoglycemia.
Diabetes Guideline Updates: Managing Hyperglycemia With Comorbidities and Precision Medicine
Recent guideline recommendations highlight the need to manage hyperglycemia alongside comorbidities and risk factors, rather than in isolation. Long-acting GLP-1 receptor agonists and SGLT-2 inhibitors are recommended for patients with cardiorenal risk factors due to their protective effects.
Glycemic Control in Chronic Kidney Disease
In healthy individuals, glucose is filtered at the glomerulus, with most reabsorbed by sodium-glucose cotransporters (SGLT2 and SGLT1) in the proximal tubule. Kidney disease can impair this process, reducing the ability to filter and reabsorb glucose, potentially causing hyperglycemia or hypoglycemia.
